Sign in Create account

Trident Lifeline Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 543616
₹366.05
▼ -39.90 (-9.83%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
92/100
Strong
Valuation
—/100
Data unavailable
Momentum
87/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹437 Cr
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
5.51%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
38.7
Free Cash Flow
₹-32 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
56.68%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
62.91%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
44.36%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
42.64%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.59
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
14.58
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
18.69%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
26.26%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
26.99%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
7.48%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
16.48%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 3 met
  • Yes Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

0 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (6.9% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 4 met
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-9.8%
Low 365.4000 · High 400.0000
1W return
-9.0%
Low 365.4000 · High 418.0000
1M return
34.6%
Low 270.0000 · High 421.0000
52W return
38.7%
Low 253.0000 · High 421.0000
Lifetime High ₹410.0000 (Sept. 28, 2026)
Lifetime Low ₹108.1500 (Oct. 10, 2022)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish4
Bearish2
5D
386.8
10D
373.4
20D
345.2
50D
293.7
100D
253.0
200D
205.2

Delivery and volume

Day avg. delivery
62.3%
Week avg. delivery
76.2%
Month avg. delivery
77.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

377.15
Pivot
First resistance388.90
Second resistance411.75
Third resistance423.50
First support354.30
Second support342.55
Third support319.70
Day RSI59.9
Day MFI51.8
Day MACD35.15
Day MACD signal30.81

Beta

1M4.89
3M2.91
1Y2.91
3Y1.20

Price change analysis

↑ 34.6%
Over 1 Month
LowHigh
270.00421.00
↑ 38.7%
Over 3 Months
LowHigh
253.00421.00
↑ 38.7%
Over 6 Months
LowHigh
253.00421.00
↑ 38.7%
Over 1 Year
LowHigh
253.00421.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹27 Cr
Net profit (June 30, 2026)
₹5 Cr
Basic EPS (June 30, 2026)
₹

Ranks #105 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter62.59%
  • FII/FPI5.25%
  • Public31.90%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 62.85% to 62.59% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 7.24% to 5.25% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 40 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
27 Mar 2026 RINKAL MAYURBHAI GAJERA Bulk Sell 60,000 263.4000 BSE
27 Mar 2026 KAMAL AMAR SHAH Bulk Buy 94,800 261.4600 BSE
23 Jan 2026 PRABHAT FINANCIAL SERVICES LIMITED Bulk Sell 73,200 289.6800 BSE
23 Jan 2026 BRIMMING WEALTH ADVISORS LLP Bulk Buy 78,000 289.7600 BSE
16 May 2024 RINKAL MAYURBHAI GAJERA Bulk Sell 63,000 178.7500 BSE
19 Mar 2024 SANDHYA SINGH GAHLOUT Bulk Buy 80,400 157.5500 BSE
19 Mar 2024 PRSSB SERVICES LIMITED Bulk Sell 80,400 157.5500 BSE
18 Mar 2024 PRSSB SERVICES LIMITED Bulk Buy 80,400 157.0000 BSE
18 Mar 2024 SANDHYA SINGH GAHLOUT Bulk Sell 80,400 157.0000 BSE
6 Mar 2024 MAYURKUMAR MANSUKHBHAI GAJERA Bulk Sell 57,600 180.0000 BSE

All bulk and block deals →

Corporate Announcements

All 13 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
3 Oct 2026 Company Update Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1 Oct 2026 Company Update Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
30 Sep 2026 Company Update Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Acquisition
30 Sep 2026 Insider Trading / SAST Trident Lifeline Ltd - 543616 - Closure of Trading Window
29 Sep 2026 Board Meeting Trident Lifeline Ltd - 543616 - Board Meeting Intimation for Consideraration And Evaluate The Proposal To Raise Funds
28 Sep 2026 AGM/EGM Trident Lifeline Ltd - 543616 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
28 Sep 2026 Company Update Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16 Sep 2026 Company Update Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Sep 2026 Company Update Trident Lifeline Ltd - 543616 - Disclosure Under Regulation 30 Of SEBI (LODR)- Intimation Of Award
5 Sep 2026 Company Update Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Newspaper Publication

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Comfortable interest coverage (14.6x)
  • Healthy liquidity (Current Ratio 1.59)
  • Strong revenue growth YoY (42.6%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Trident Lifeline Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.